Christopher Paul Day
Newcastle University · 266 works · 50,146 citations · h-index 100
Top works
- Steatohepatitis: A tale of two “hits”?
- The natural history of nonalcoholic fatty liver: A follow-up study
- The NAFLD fibrosis score
- QT dispersion: an indication of arrhythmia risk in patients with long QT intervals.
- Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- Hepatic steatosis: Innocent bystander or guilty party?
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
- Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients
- Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance
- Non-alcoholic steatohepatitis: another disease of affluence
- Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease
- Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers
- HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
- Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
- The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study
- Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
- Reduction in QT dispersion by sotalol following myocardial infarction
- Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis